Two alleles work together to influence multiple sclerosis risk, a Duke University-led team has found.
Tempus will provide sequencing and analysis for glioblastoma patients in a clinical trial at Duke using engineered poliovirus as a treatment.
Heterozygous deletions at the chromosome 22q11.2 locus contribute to kidney problems in individuals with DiGeorge syndrome or congenital urogenital conditions.
Robert Cook-Deegan and Subhashini Chandrasekharan discuss genetic testing patents in the New England Journal of Medicine.
Researchers screened cancer cell lines to detect mutations and drug combinations that might sensitize tumors to drugs that impair anti-apoptosis proteins.
The organizations in the consortium will identify, characterize, and catalog human biological molecules affected by physical activity in volunteer biosamples.
By overlaying epilepsy genetic data onto co-expressed gene networks from post-mortem brain samples, researchers proposed a 320-gene expression network for epilepsy.
Duke University's Allen Roses, known for his Alzheimer's disease research and more, has died.
Experts led by Duke neuroscientist Allen Roses developed the database hoping to boost researchers' ability to explore the role of short structural variants in complex diseases.
Results from a study have spurred a new prospective trial comparing arrays, sequencing, and several single-marker assays in men receiving hormonal therapies.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.